Navigation Links
DNA sequencing pioneer receives 2011 Russ Prize
Date:1/6/2011

"The sequencer has enabled the development of important drugs that are crucial to the realization of personalized medicine and therefore have saved lives. It's also true that many people wrongly accused of crimes have been exonerated and been given back their lives," he said.

Ohio University President Roderick J. McDavis said Fritz and Dolores Russ established a legacy with the Russ Prize.

"The prize is just one way that we can help honor the achievements of extraordinary engineers whose work improves the human condition," he said. "Ohio University is privileged to be a part of the Russ's extraordinary legacy of fostering and honoring life-changing engineering research and advances across the globe."

Hood is the sixth recipient of the biennial Russ Prize, which is modeled after the Nobel Prize. He will receive the award at a ceremony in Washington D.C., on Feb. 22.

About Leroy Hood

With a research interest in genetics, Hood recognized the need for new tools to decipher biological information. Integrating new ideas in chemistry, engineering, and software, he led a team at the California Institute of Technology that developed the sequencer in the 1980s. In 1981, he founded Applied Biosystems, Inc (ABI), an instrument company to commercialize the DNA sequencer and three other instruments developed in the Hood lab. By the late 1980s, ABI had developed a commercial DNA sequencer that could be used in any laboratory.

Prior to automated sequencing, the process of manual sequencing was slow and laborious. It took 30 years, for instance, to sequence the genome of a cold virus. Today, the genome of a virus of the same size can be sequenced in less than an hour.

Hood was an early pioneer in promoting the Human Genome Project and served on a National Academies committee that ultimately made the recommendations that led to the project's start in 1990.

He has won numerous awards in recognition
'/>"/>

Contact: Colleen Carow
carow@ohio.edu
740-593-1488
Ohio University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. UK researchers contribute to sequencing strawberry genome
2. New annotated database sifts through mountains of sequencing data to find gene promoters
3. Scientists and physicians use genetic sequencing to identify and treat unknown disease
4. Your genome in minutes: New technology could slash sequencing time
5. Genome 10K Project announces first 101 species for genome sequencing
6. A new read on DNA sequencing
7. Knome Awards Human Exome Sequencing and Analysis to Biomedical Researchers
8. Scripps research team wins $5.1 million to develop DNA sequencing technology
9. Sequencing of cacao genome will help US chocolate industry, subsistence farmers
10. NHGRI funds development of third generation DNA sequencing technologies
11. Graphene may hold key to speeding up DNA sequencing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/10/2015)... BOSTON and TELTOW, Germany ... SensoMotoric Instruments (SMI), a world leader in Eye ... the completion of its OEM Eye Tracking Platform for ... Eye Tracking Platform contains reference designs for seamless integration ... kiosk systems, virtual reality HMDs and augmented reality smart ...
(Date:8/6/2015)... , Aug. 6, 2015 Synaptics ... of human interface solutions, today announced collaboration with ... on Windows 10. Microsoft leveraged Synaptics, deep expertise ... operating system. Through stringent testing, ... fully certified with Microsoft,s Precision TouchPad (PTP) specification ...
(Date:8/4/2015)... Research and ... addition of the "Digital Forensics Market ... (Computer Forensics, Network Forensics, Mobile Device Forensics, ... and Region - Global Forecast to 2020" ... By Component (Hardware, Software, and Service), Sub-Segment ...
Breaking Biology News(10 mins):SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3Synaptics Chosen for Human Interface Co-Development on Windows 10 2Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2
... animals don,t pick their mates by pure chance it,s ... decades of examining his work, experts agree that he pretty ... is, "What have we learned since then?" asks a Texas ... an evolutional biologist who has studied Darwin,s work for years, ...
... RICHLAND, Wash. -- DNA might be the blueprint for ... to understand how and which proteins work together have ... unobtrusive enough to use in live cells. Using the ... a well-studied complex of proteins known as RNA polymerase. ...
... T-cells react to foreign protein fragments and therefore are ... attack the body,s own material are in most cases ... however, undergo a kind of reeducation to become "regulatory ... group led by immunologist Professor Ludger Klein of LMU ...
Cached Biology News:Why do we choose our mates? Ask Charles Darwin, prof says 2TRAPping proteins that work together inside living cells 2TRAPping proteins that work together inside living cells 3They are young and need the job: A second chance for dangerous T-cells 2They are young and need the job: A second chance for dangerous T-cells 3
(Date:8/28/2015)... - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: ... the development of autologous cell therapies, today reported ... 2015, corporate highlights, and near-term milestones.  The company,s ... www.sedar.com ,  www.edgar.com and at ... to launch its RCS-01 treatment for aging and ...
(Date:8/28/2015)... ... ... launch of FireflySci Inc. (FFS) in early 2015, the company continues to shake up the ... Fonz in a lab coat and Large Marge have been posted on the company’s Facebook ... FireflySci is proud to be the only cuvette manufacturer is the world that has an ...
(Date:8/27/2015)... VA (PRWEB) , ... August 27, 2015 , ... ... contractors solve complex business problems, is pleased to announce their ranking as one of ... annual ranking of the fastest-growing private companies across the nation. , “It is truly ...
(Date:8/27/2015)... 2015 /PRNewswire/ - Portage Biotech Inc. ("Portage") (OTC ... Pharmaceutical Holding Company Limited (Biohaven), announced today that ... of BHV-0223, a glutamate modulating agent. Biohaven filed ... recently obtained clearance from the U.S. Food and ... Portage holds 54% equity interest in Biohaven, a ...
Breaking Biology Technology:RepliCel Reports Second Quarter 2015 Financial Results 2RepliCel Reports Second Quarter 2015 Financial Results 3RepliCel Reports Second Quarter 2015 Financial Results 4RepliCel Reports Second Quarter 2015 Financial Results 5Cuvette Manufacturer FireflySci Launches Back to School Deals with Complimentary Shipping On All Orders 2Capital Edge Consulting Makes Inc. 5000 List of America’s Fastest-Growing Private Companies 2Capital Edge Consulting Makes Inc. 5000 List of America’s Fastest-Growing Private Companies 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4
... Sequella, Inc., a clinical-stage biopharmaceutical company focused ... receipt of a Small Business Innovation Research (SBIR) ... Allergy and Infectious Diseases (NIAID), National Institutes of ... the company,s novel tuberculosis (TB) lead dipiperidine drug ...
... the unexpected happens, www.WhatWillYourPlanBe.com offers post college-aged women ... healthMONTVALE, N.J., Feb. 17 Many young women ... go according to plan, particularly when it comes ... the reality is that the unexpected often happens ...
... to EUR1.06bn, - Adjusted Earnings per Share Improves by 36.6% From ... EBITDA Margin Rises From 19.0 to 19.5%, - CEO Dr. Axel ... considers itself well equipped to meet the global challenges in, ... in, the core business.", , ...
Cached Biology Technology:Sequella Receives SBIR Funding Grant from the NIH for Further Development of Tuberculosis Drug SQ609 2Sequella Receives SBIR Funding Grant from the NIH for Further Development of Tuberculosis Drug SQ609 3Helping Young Women Succeed in Today's Unpredictable World 2Helping Young Women Succeed in Today's Unpredictable World 3Helping Young Women Succeed in Today's Unpredictable World 4Following a Record Year in 2008 Gerresheimer Again Sets its Sights on Substantial Growth in 2009 2Following a Record Year in 2008 Gerresheimer Again Sets its Sights on Substantial Growth in 2009 3Following a Record Year in 2008 Gerresheimer Again Sets its Sights on Substantial Growth in 2009 4
Sf21 Insect Cells (Frozen) in Max-XP Medium...
Lyophilized solid. Suitable for evaluating functional activity of human complement components and for other research requiring a high level of hemolytic activity. ...
... Ciphergen's ProteinChip arrays have been developed ... biological samples. A variety of ProteinChip ... proteins according to their unique biochemical ... spots, allowing side-by-side sample comparison, and ...
... ProteinChip arrays have been developed for ... samples. A variety of ProteinChip chemical ... according to their unique biochemical properties. ... allowing side-by-side sample comparison, and the ...
Biology Products: